Logo image of ILAG

INTELLIGENT LIVING APPLICATI (ILAG) Stock Fundamental Analysis

NASDAQ:ILAG - Nasdaq - KYG4804S1012 - Common Stock - Currency: USD

0.5201  -0.03 (-4.76%)

Fundamental Rating

2

ILAG gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 41 industry peers in the Building Products industry. ILAG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ILAG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ILAG had negative earnings in the past year.
In the past year ILAG has reported a negative cash flow from operations.
In the past 5 years ILAG always reported negative net income.
In the past 5 years ILAG always reported negative operating cash flow.
ILAG Yearly Net Income VS EBIT VS OCF VS FCFILAG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M

1.2 Ratios

ILAG's Return On Assets of -25.56% is on the low side compared to the rest of the industry. ILAG is outperformed by 90.24% of its industry peers.
Looking at the Return On Equity, with a value of -29.20%, ILAG is doing worse than 82.93% of the companies in the same industry.
Industry RankSector Rank
ROA -25.56%
ROE -29.2%
ROIC N/A
ROA(3y)-17.44%
ROA(5y)-15.86%
ROE(3y)-19.69%
ROE(5y)-24.78%
ROIC(3y)N/A
ROIC(5y)N/A
ILAG Yearly ROA, ROE, ROICILAG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

With a Gross Margin value of 17.47%, ILAG is not doing good in the industry: 87.80% of the companies in the same industry are doing better.
ILAG's Gross Margin has improved in the last couple of years.
ILAG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.71%
GM growth 5Y11.67%
ILAG Yearly Profit, Operating, Gross MarginsILAG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

More info and screens

5

2. Health

2.1 Basic Checks

ILAG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ILAG has about the same amount of shares outstanding.
The number of shares outstanding for ILAG remains at a similar level compared to 5 years ago.
ILAG has a worse debt/assets ratio than last year.
ILAG Yearly Shares OutstandingILAG Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ILAG Yearly Total Debt VS Total AssetsILAG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

ILAG has an Altman-Z score of 2.98. This is not the best score and indicates that ILAG is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.98, ILAG is in line with its industry, outperforming 46.34% of the companies in the same industry.
A Debt/Equity ratio of 0.02 indicates that ILAG is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.02, ILAG belongs to the top of the industry, outperforming 85.37% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 2.98
ROIC/WACCN/A
WACC9.47%
ILAG Yearly LT Debt VS Equity VS FCFILAG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

ILAG has a Current Ratio of 6.21. This indicates that ILAG is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 6.21, ILAG belongs to the top of the industry, outperforming 95.12% of the companies in the same industry.
ILAG has a Quick Ratio of 2.66. This indicates that ILAG is financially healthy and has no problem in meeting its short term obligations.
ILAG has a Quick ratio of 2.66. This is amongst the best in the industry. ILAG outperforms 90.24% of its industry peers.
Industry RankSector Rank
Current Ratio 6.21
Quick Ratio 2.66
ILAG Yearly Current Assets VS Current LiabilitesILAG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for ILAG have decreased by -5.42% in the last year.
ILAG shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.50%.
ILAG shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.57% yearly.
EPS 1Y (TTM)-5.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-111.67%
Revenue 1Y (TTM)16.5%
Revenue growth 3Y-15.72%
Revenue growth 5Y-7.57%
Sales Q2Q%-32.7%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ILAG Yearly Revenue VS EstimatesILAG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 5M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ILAG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ILAG Price Earnings VS Forward Price EarningsILAG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ILAG Per share dataILAG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ILAG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTELLIGENT LIVING APPLICATI

NASDAQ:ILAG (8/6/2025, 8:00:02 PM)

0.5201

-0.03 (-4.76%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)11-29 2022-11-29/bmo
Earnings (Next)N/A N/A
Inst Owners0.72%
Inst Owner Change0%
Ins Owners52.48%
Ins Owner ChangeN/A
Market Cap10.80M
AnalystsN/A
Price TargetN/A
Short Float %4.69%
Short Ratio0.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.44
P/FCF N/A
P/OCF N/A
P/B 0.85
P/tB 0.85
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0.36
BVpS0.61
TBVpS0.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.56%
ROE -29.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.47%
FCFM N/A
ROA(3y)-17.44%
ROA(5y)-15.86%
ROE(3y)-19.69%
ROE(5y)-24.78%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.71%
GM growth 5Y11.67%
F-Score4
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 14.44%
Cap/Sales 1.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.21
Quick Ratio 2.66
Altman-Z 2.98
F-Score4
WACC9.47%
ROIC/WACCN/A
Cap/Depr(3y)534.64%
Cap/Depr(5y)337.85%
Cap/Sales(3y)19.01%
Cap/Sales(5y)11.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-111.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.5%
Revenue growth 3Y-15.72%
Revenue growth 5Y-7.57%
Sales Q2Q%-32.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.83%
OCF growth 3YN/A
OCF growth 5YN/A